All GSK articles – Page 3
-
BusinessGSK cuts US jobs in push for savings
Research Triangle Park site bears the brunt as drugmaker consolidates research in Philadelphia and Stevenage, UK
-
NewsEbola vaccine passes first safety hurdle
Researchers hope to begin larger trials of its effectiveness in west Africa soon
-
-
NewsBlaze destroys Nottingham sustainable chemistry lab
The cause of the fire that destroyed the £20 million centre that was still under construction is unknown
-
Business
Cipla targets asthma market with Advair copy
Indian pharma company Cipla has launched a generic version of GSK’s best selling drug
-
Business
GSK’s China troubles continue
Analysts say stings will only drive corruption into less visible channels
-
BusinessEMA wrangles restrain trial data progress
Attempts to balance industry and research interests on transparency draw suggestions of improper collusion
-
BusinessPharma vies to unleash immune system power on cancer
Immuno-oncological drugs look set to earn billions and significantly lengthen patients’ lives
-
Business
Drug giants settle mismarketing lawsuits
Pfizer and GSK settle claims over promoting drugs for unapproved uses in the US
-
Business
Chinese police hand GSK bribery case to prosecutors
Investigation alleges senior manager ordered staff to hand out bribes
-
NewsPledge to create 2000 new STEM posts
UK government teams up with industry as part of campaign to inspire young people to take up science and engineering
-
-
Business$25bn-plus trade sharpens pharma giants’ focus
Novartis’ asset swaps with GSK and Eli Lilly are the latest steps in an ongoing streamlining process
-
Business
GSK corruption investigation widens
BBC investigation airs allegations of misconduct in Poland
-
Business
GSK investigates bribery claims in the Middle East
Leaked emails claim GlaxoSmithKline bribed Iraqi doctors and healthcare officials
-
Business
Contamination troubles strike GSK
GlaxoSmithKline is warned over contamination at an Ireland plant, and has recalled Alli from US retailers over tampering concerns.
-
Business
Pharma giants plan new public–private collaborations
AstraZeneca and GSK will partner with UK academics to work on early drug discovery
-
Business
AstraZeneca boosts open innovation efforts
Web portal will make collaborative drug discovery easier
-
BusinessJ&J puts trial data in independent hands
Yale University’s YODA seeks to help pharma avoid the dark side by acting as gatekeeper for patient records
-
FeatureThe hunt for innovation
Big pharma companies are embracing a more open and collaborative approach. Nuala Moran discovers who’s working with whom